Case study: a new approach to prostate cancer treatment

How Maidstone and Tunbridge Wells NHS Trust is working with BXTAccelyon to offer 4D brachytherapy to patients, reducing the need for anesthesia.

The technology
4D Brachytherapy is a hybrid approach to LDR brachytherapy for prostate cancer.
It combines the benefits of both a two-stage and one-stage implant technique to create a new real-time and dynamic approach to seed brachytherapy.
It not only eliminates some of the disadvantages aligned with each approach, but also introduces a host of added benefits.

The benefits:
An effective and highly-targeted treatment option
A time-efficient procedure for both patients and clinicians
Reduced cost for the hospital – Maidstone Hospital has shortened the duration of the operating list by almost 30%
Side effects are significantly reduced for patients

The impact
Maidstone and Tunbridge Wells NHS Trust has identified 4D brachytherapy as one of the most-effective and time-efficient means of treating prostate cancer.